Your browser is no longer supported. Please, upgrade your browser.
Settings
EDAP EDAP TMS SA daily Stock Chart
EDAP [NASD]
EDAP TMS SA
Index- P/E17.81 EPS (ttm)0.16 Insider Own6.00% Shs Outstand28.76M Perf Week-2.73%
Market Cap81.97M Forward P/E50.89 EPS next Y0.06 Insider Trans0.00% Shs Float12.42M Perf Month-3.72%
Income4.70M PEG5.94 EPS next Q0.00 Inst Own10.70% Short Float3.82% Perf Quarter-10.38%
Sales39.40M P/S2.08 EPS this Y-207.10% Inst Trans-8.88% Short Ratio7.67 Perf Half Y-32.46%
Book/sh0.64 P/B4.46 EPS next Y-64.33% ROA- Target Price6.50 Perf Year-49.56%
Cash/sh- P/C- EPS next 5Y3.00% ROE- 52W Range2.43 - 6.57 Perf YTD-30.99%
Dividend- P/FCF- EPS past 5Y41.60% ROI-1.20% 52W High-58.45% Beta1.11
Dividend %- Quick Ratio- Sales past 5Y6.30% Gross Margin44.50% 52W Low12.35% ATR0.12
Employees165 Current Ratio2.80 Sales Q/Q5.10% Oper. Margin4.80% RSI (14)30.62 Volatility2.93% 3.19%
OptionableYes Debt/Eq- EPS Q/Q358.30% Profit Margin11.80% Rel Volume6.56 Prev Close2.85
ShortableYes LT Debt/Eq- EarningsAug 25 BMO Payout0.00% Avg Volume61.89K Price2.73
Recom2.00 SMA20-6.42% SMA50-9.59% SMA200-22.65% Volume20,300 Change-4.21%
Jul-28-14Downgrade Northland Capital Outperform → Market Perform $6 → $3.50
Jun-16-14Initiated H.C. Wainwright Buy $6
Mar-05-13Initiated Northland Capital Outperform $6
Nov-18-10Reiterated Morgan Joseph Buy $3 → $5.25
Aug-20-09Reiterated Roth Capital Hold $2.50 → $5
Nov-24-08Reiterated Roth Capital Hold $2.50
Mar-26-08Reiterated Roth Capital Hold $6 → $4.50
Nov-09-07Reiterated Roth Capital Hold $7 → $6
Mar-16-07Reiterated Roth Capital Hold $8.50 → $7
Jan-24-07Reiterated Roth Capital Hold $6.50 → $8.50
Sep-12-16 08:30AM  EDAP Installs Ablatherm Robotic® HIFU at Leading Academic Medical Center GlobeNewswire
Sep-06-16 08:30AM  EDAP TMS to Present at the 18th Annual Rodman and Renshaw Global Investment Conference GlobeNewswire
Aug-30-16 09:28AM  EDAP TMS SA :EDAP-US: Earnings Analysis: Q1, 2016 By the Numbers : August 30, 2016
Aug-25-16 07:07AM  Q2 2016 Edap Tms SA Earnings Release - Before Market Open
07:00AM  EDAP Reports 69% Growth in HIFU Revenues and Operating Profit for First Half 2016 GlobeNewswire
Aug-22-16 08:30AM  EDAP's Ablatherm® Robotic HIFU Treats First Patient at Henry Ford Hospital in Detroit GlobeNewswire
Aug-11-16 08:30AM  EDAP to Report Second Quarter 2016 Financial Results on August 25, 2016 GlobeNewswire
Jun-16-16 08:30AM  EDAP Announces First HIFU Treatments Performed in New England GlobeNewswire
Jun-14-16 08:37AM  First HIFU patient treated at Allied Urological Services in New York City with the Ablatherm® Robotic HIFU device GlobeNewswire
Jun-08-16 09:43AM  EDAP TMS SA :EDAP-US: Earnings Analysis: Q1, 2016 By the Numbers : June 8, 2016
May-18-16 07:07AM  Q1 2016 Edap Tms SA Earnings Release - Before Market Open
07:00AM  EDAP First Quarter 2016 Revenue Increases 40% Year-over-Year to 8.7 Million GlobeNewswire
May-10-16 08:30AM  EDAP to Report First Quarter 2016 Results on May 18, 2016 GlobeNewswire
May-04-16 08:30AM  EDAP Announces Presentations and Live Demonstrations of Ablatherm® Robotic HIFU at 2016 American Urology Association Annual Meeting, May 6-10, 2016 GlobeNewswire
Apr-28-16 08:30AM  EDAP Receives Brazilian Regulatory Approval for Focal One® HIFU Device GlobeNewswire
Apr-25-16 08:30AM  Houston Methodist Hospital, Houston, TX Acquires and Installs EDAPs Ablatherm® Robotic HIFU GlobeNewswire
Apr-18-16 08:30AM  EDAPs Ablatherm® Robotic HIFU Deployed by HIFU Solution GlobeNewswire
Apr-14-16 03:15PM  EDAP TMS SA Closes $11.5 Million Registered Direct Offering GlobeNewswire
Apr-08-16 01:04PM  EDAP TMS SA Financials
Apr-07-16 10:09AM  EDAP TMS SA :EDAP-US: Earnings Analysis: Q4, 2015 By the Numbers -8.88%
09:24AM  EDAP TMS SA :EDAP-US: Earnings Analysis: 2015 By the Numbers
09:13AM  EDAP TMS SA to Raise $11.5 Million in Registered Direct Offering GlobeNewswire
Apr-06-16 07:55AM  EDAP Submits 510(k) Application for FDA Clearance of Focal One HIFU GlobeNewswire +5.42%
Apr-04-16 07:07AM  Q4 2015 Edap Tms SA Earnings Release - Before Market Open
07:00AM  EDAP Reports 20% Revenue Growth to EUR 32.3 Million and EUR 0.5 Million Operating Profit for Full-year 2015 GlobeNewswire
Mar-24-16 08:38AM  EDAP to Report Fourth Quarter and Full Year 2015 Results on April 4, 2016 at noodls
08:30AM  EDAP to Report Fourth Quarter and Full Year 2015 Results on April 4, 2016 GlobeNewswire
Mar-22-16 08:36AM  EDAP HIFU Advancements Highlighted at International Symposium on Therapeutic Ultrasound at noodls
08:30AM  EDAP HIFU Advancements Highlighted at International Symposium on Therapeutic Ultrasound GlobeNewswire
Mar-17-16 08:30AM  EDAP HIFU and Lithotripsy Devices Showcased at 31st Annual European Association of Urology Congress GlobeNewswire
Mar-14-16 01:48PM  John Grisham book turns spotlight on futuristic cancer treatment
Mar-10-16 08:30AM  EDAP Announces Sylvester Comprehensive Cancer Center in Miami as First Certified U.S. Ablatherm® Robotic HIFU Site GlobeNewswire -5.02%
Mar-07-16 08:41AM  First Patients Treated With EDAPs Ablatherm® Robotic HIFU in New York GlobeNewswire
Jan-25-16 08:30AM  First Prostate Ablation Treatments Performed Using EDAPs FDA Approved Ablatherm® Robotic HIFU at Sylvester Comprehensive Cancer Center, in Miami, Florida GlobeNewswire
Jan-19-16 08:31AM  EDAP Announces Results of Worlds First Focal HIFU Trial GlobeNewswire +5.92%
Jan-06-16 08:30AM  EDAP Receives Japanese Approval for Quanta Litho Laser; Secures Exclusive Distribution Rights in Japan GlobeNewswire
Dec-23-15 12:55PM  EDAP TMS SA Earnings Analysis: Q3, 2015 By the Numbers
Dec-21-15 08:30AM  EDAP Reports Sale of Ablatherm Robotic HIFU to Sylvester Comprehensive Cancer Center GlobeNewswire +7.33%
Dec-11-15 08:30AM  EDAP Receives Russian Regulatory Approval for Focal One(R) HIFU Device GlobeNewswire
Dec-09-15 08:30AM  EDAP Reports Installation of Ablatherm Robotic HIFU at University of Southern California GlobeNewswire -6.09%
Nov-24-15 11:00AM  Positive Outcomes From Prostate Cancer Hemiablation Study With EDAP Ablatherm Robotic HIFU Presented at 109th French Urology Congress GlobeNewswire
Nov-23-15 08:05AM  Direction of Market Influences - Research on EVINE Live, hhgregg, Abeona Therapeutics and Edap Tms Accesswire
Nov-18-15 05:45PM  EDAP Reports Third Quarter 2015 Financial Results and Operational Update GlobeNewswire
07:07AM  Q3 2015 Edap Tms SA Earnings Release - After Market Close
Nov-12-15 04:05PM  EDAP to Hold Third Quarter 2015 Conference Call on November 19, 2015 GlobeNewswire
01:30PM  Pacific Biosciences' (PACB) SMRT Sequencing Holds Promise
09:40AM  WaferGen (WGBS) Q3 Loss Narrows, Revenues Improve Y/Y
08:30AM  EDAP Records First Three U.S. Orders for Ablatherm HIFU GlobeNewswire
Nov-11-15 08:30AM  EDAP Announces Dismissal of Class Action Lawsuit GlobeNewswire -6.75%
Nov-10-15 08:58AM  EDAP TMS SA Due Diligence Report: Upward Trend and Upcoming Catalysts; Investors Anxious Accesswire
08:30AM  EDAP Announces Focal One(R) HIFU Sale to Clinica Santa Maria de Santiago de Chile GlobeNewswire
Nov-09-15 10:20AM  Evolent Q3 Loss Narrower than Expected; Revenues Rise Y/Y
08:30AM  EDAP Receives FDA Approval for Ablatherm HIFU GlobeNewswire
Nov-06-15 09:58AM  Masimo (MASI) Tops Q3 Earnings & Revenues; View Raised
Nov-05-15 12:20PM  Bruker Outshines Q3 Earnings and Revenues, '15 EPS View Up
Nov-03-15 10:48AM  PRA Health (PRAH) Tops Q3 Earnings, Revenues; View Raised
08:30AM  EDAP Reports on Recent, Active Urology Congress and Clinical Activity GlobeNewswire
Oct-15-15 11:13AM  EDAP Direct De Novo for Ablatherm HIFU Replaced by 510(k) GlobeNewswire
Sep-25-15 02:45PM  Thermo Fisher on Track with Life Technologies Synergy +8.65%
Sep-24-15 12:30PM  Cyberonics Investors Okay Sorin Deal; LivaNova Coming Up +6.34%
09:25AM  EDAP Reports Growing Momentum in Europe for HIFU Treatment of Prostate Cancer GlobeNewswire
Sep-22-15 08:44AM  IRadimed Corporation (IRMD) in Focus: Stock Up 6.2%
Sep-18-15 09:30AM  New Strong Buy Stocks for September 18th
08:35AM  Will Edap Tms (EDAP) Continue to Surge Higher?
Sep-16-15 11:44AM  EDAP TMS SA Earnings Q2, 2015
Sep-11-15 02:00PM  EDAP TMS SA: Leads amongst peers with strong fundamentals +6.21%
09:32AM  EDAP TMS SA (EDAP) in Focus: Stock Adds 10.9% in Session
Sep-02-15 08:30AM  EDAP TMS to Present at Rodman and Renshaw Global Investment Conference GlobeNewswire
Aug-27-15 07:19AM  Wednesday's After-Hours Movers: Workday, Williams-Sonoma, Avago And More
Aug-26-15 04:01PM  EDAP Reports Strong Year-over-Year Revenue Growth in Second Quarter 2015 GlobeNewswire
07:07AM  Q2 2015 Edap Tms SA Earnings Release - After Market Close
Aug-25-15 08:30AM  EDAP Provides Formal Response to FDA Addressing All Concerns Raised in July 2015 Ablatherm HIFU Letter GlobeNewswire +8.55%
Aug-19-15 08:30AM  EDAP to Hold Second Quarter 2015 Conference Call on August 27, 2015 GlobeNewswire
Jul-21-15 08:30AM  EDAP Receives Feedback From FDA on Direct De Novo 510(k) Petition for Ablatherm HIFU GlobeNewswire
Jul-14-15 08:30AM  EDAP Names Francois Dietsch Chief Financial Officer GlobeNewswire
Jul-07-15 08:30AM  EDAP's Focal One(R) HIFU Device Adopted by Two University Hospitals in Switzerland GlobeNewswire
Jul-02-15 08:30AM  EDAP Announces Senior Management Transition GlobeNewswire
Jun-09-15 08:30AM  EDAP Announces Focal One(R) HIFU Installation at Germany's Martini-Klinik GlobeNewswire
May-28-15 05:40PM  Thursday's After-Hours Movers: GameStop, Deckers Outdoor And More
May-12-15 04:05PM  EDAP Reports First Quarter 2015 Results GlobeNewswire
07:07AM  Q1 2015 Edap Tms SA Earnings Release - After Market Close
May-06-15 08:30AM  EDAP to Report First Quarter 2015 Results on May 13, 2015 GlobeNewswire
Apr-01-15 04:20PM  EDAP Reports Fourth Quarter and Full Year 2014 Results GlobeNewswire
07:07AM  Q4 2014 Edap Tms SA Earnings Release - After Market Close
Mar-31-15 08:30AM  EDAP Announces Sale of First Focal One(R) HIFU Device in North America GlobeNewswire
Mar-26-15 04:05PM  EDAP to Participate in Major, Multi-Partner Liver Cancer Development Project GlobeNewswire
Mar-17-15 08:30AM  EDAP to Report Fourth Quarter and Full-Year 2014 Results on April 2, 2015 GlobeNewswire
Mar-09-15 08:30AM  EDAP Announces Plans to Pursue Direct De Novo 510(k) Petition in Lieu of PMA for Its Ablatherm HIFU GlobeNewswire -8.91%
Feb-26-15 08:30AM  EDAP Expands Product Portfolio With New Urological Stone Lasers GlobeNewswire +5.82%
Jan-09-15 10:06AM  Friday's Morning Movers: Earnings Start To Trickle In +25.43%
08:40AM  EDAP's Focal One HIFU Device Approved by Health Canada GlobeNewswire
Nov-20-14 07:41AM  EDAP Reports Continued Strong Growth in Third Quarter 2014 at noodls +26.92%
07:30AM  EDAP Reports Continued Strong Growth in Third Quarter 2014 GlobeNewswire
Nov-06-14 08:37AM  EDAP Receives FDA Guidance on PMA for Ablatherm-HIFU at noodls
08:30AM  EDAP Receives FDA Guidance on PMA for Ablatherm-HIFU GlobeNewswire
Nov-04-14 08:33AM  EDAP to Report Third Quarter 2014 Results on November 20, 2014 at noodls
08:30AM  EDAP to Report Third Quarter 2014 Results on November 20, 2014 GlobeNewswire
Oct-21-14 08:32AM  EDAP Announces Sale of Focal One(R) HIFU Device to Nantes-Atlantis Urology Clinic in France at noodls
08:30AM  EDAP Announces Sale of Focal One(R) HIFU Device to Nantes-Atlantis Urology Clinic in France GlobeNewswire
Oct-13-14 09:00AM  EDAP Presents Results of Its Ablatherm-HIFU FDA Study at 4th International Symposium of the Focused Ultrasound Foundation, Washington D.C. GlobeNewswire +17.80%
EDAP TMS S.A., together with its subsidiaries, develops, produces, markets, distributes and maintains a portfolio of minimally-invasive medical devices for the treatment of urological diseases worldwide. The company operates in two divisions: High Intensity Focused Ultrasound (HIFU), and Urology Devices and Services (UDS). The HIFU division develops, manufactures, and markets devices for the minimally invasive destruction of various types of localized tumors using HIFU technology. It offers Ablatherm, a HIFU device for the treatment of organ-confined prostate cancer, referred to as T1-T2 stage; and Focal One device, a HIFU robotic device for the focal therapy of localized prostate cancer. This division also leases equipment; sells disposables and spare parts; and offers maintenance services. The UDS division develops, manufactures, markets, and services medical devices for the minimally invasive diagnosis or treatment of urological disorders, primarily urinary stones and other clinical indications. It offers lithotripters, such as Sonolith i-move and Sonolith i-sys for the treatment of urinary tract stones by means of extracorporeal shockwave lithotripsy technology. This division also leases lithotripters; sells disposables and spare parts; and provides maintenance services. The company markets and sells its products through its direct marketing and sales organization, as well as through third-party distributors and agents. Its customers include public and private hospitals, urology clinics, and research institutions. The company was founded in 1979 and is based in Vaulx-en-Velin, France.